Assessment with MR is essential for the early detection of rheumatoid arthritis in the hands and the monitoring of drug therapy, but hand studies are not cost-effective. That's where the Japanese firm MR Technology of Tsukuba, in the prefecture of Ibaraki, comes in.
Assessment with MR is essential for the early detection of rheumatoid arthritis in the hands and the monitoring of drug therapy, but hand studies are not cost-effective. That's where the Japanese firm MR Technology of Tsukuba, in the prefecture of Ibaraki, comes in.
The company, working with the Institute of Applied Physics at the University of Tsukuba, has developed a compact whole-hand MRI system using a 0.3T permanent magnet with a 16-cm gap. The scanner, with a 1.5 × 2-m footprint, produces an ellipsoidal imaging space covering 22 × 22 × 8 cm.
In a session at the International Society for Magnetic Resonance in Medicine meeting in May, the research team presented clinical experience with the scanner. Exams visualizing the whole hand were accomplished in six minutes.
Images included a fat-suppressed 2D scan obtained with a STIR-3D-FSE sequence acquired in less than 11 minutes.
A 3D maximum intensity projection image reconstructed from the fat-suppressed 3D image data set showed suppression of the bone marrow fat signal while visualizing long T2-weighted data returned by joint fluid and blood.
The researchers concluded that the system has potential to be used for whole-hand examinations to assess patients with rheumatoid arthritis.
-By Greg Freiherr
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.